PluvictoTM plus standard of care (ARPI + ADT) significantly reduced risk of progression or death by 28% (HR 0.72) versus SoC alone, with positive trend in OS (HR 0.84) in PSMA+ metastatic ...
New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society ...
A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess ...
A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...
A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...
A multi-centre study whose leads include London-based researchers has found a new imaging solution that can more effectively ...
The Co-PSMA trial has successfully met its primary endpoint, demonstrating that 64 Cu-SAR-bisPSMA PET/CT detects significantly more lesions per patient than the SOC, 68 Ga-PSMA-11 PET/CT. This result ...
New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...
Morrow is now devoting his life to prostate cancer advocacy and urging other younger, high-risk men to get screened early. He regularly visits Walter Reed National Military Medical Center where he was ...
A month ago, SCAN Health Plan revealed it would enter a new state with its Medicare Advantage (MA) coverage offerings. Now, the not-for-profit insurer is offering a more detailed look at its slate of ...
SCAN Health Plan will expand its 2026 Medicare Advantage benefits with $0 copays and higher dental, vision and allowance coverage amid funding and coverage cuts from larger insurers such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback